Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB01142_nanopub.RAnrmrPLJpAWlYdanEcQD97uvGfIS8w0JzIh06LIBw870#assertion>. }
Showing items 1 to 26 of
26
with 100 items per page.
- drugbank:DB01142 type drugbank_vocabulary:Drug assertion.
- drugbank:DB01142 label "Doxepin [drugbank:DB01142]" assertion.
- drugbank:DB01142 seeAlso doxepin.htm assertion.
- drugbank:DB01142 seeAlso doxepin-capsules.html assertion.
- drugbank:DB01142 seeAlso DB01142 assertion.
- drugbank:DB01142 description "Doxepin hydrochloride is a dibenzoxepin-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, doxepin does not affect mood or arousal, but may cause sedation. In depressed individuals, doxepin exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. Tertiary amine TCAs, such as doxepin and amitriptyline, are more potent inhibitors of serotonin reuptake than secondary amine TCAs, such as nortriptyline and desipramine. TCAs also down-regulate cerebral cortical β-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine H<sub>1</sub> receptors, α<sub>1</sub>-adrenergic receptors and muscarinic receptors, which accounts for their sedative, hypotensive and anticholinergic effects (e.g. blurred vision, dry mouth, constipation, urinary retention), respectively. Doxepin has less sedative and anticholinergic effects than amitriptyline. See toxicity section below for a complete listing of side effects. Doxepin may be used to treat depression and insomnia. Unlabeled indications include chronic and neuropathic pain, and anxiety. Doxepin may also be used as a second line agent to treat idiopathic urticaria." assertion.
- drugbank:DB01142 identifier "drugbank:DB01142" assertion.
- drugbank:DB01142 title "Doxepin" assertion.
- drugbank:DB01142 drugbank_vocabulary:x-cas cas:1668-19-5 assertion.
- drugbank:DB01142 drugbank_vocabulary:drugbank-id "APRD00398" assertion.
- drugbank:DB01142 drugbank_vocabulary:drugbank-id "DB01142" assertion.
- drugbank:DB01142 bio2rdf_vocabulary:x-identifiers.org DB01142 assertion.
- drugbank:DB01142 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB01142" assertion.
- drugbank:DB01142 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB01142 bio2rdf_vocabulary:identifier "DB01142" assertion.
- drugbank:DB01142 drugbank_vocabulary:x-wikipedia wikipedia:Doxepin assertion.
- drugbank:DB01142 drugbank_vocabulary:x-pharmgkb pharmgkb:PA449409 assertion.
- drugbank:DB01142 drugbank_vocabulary:x-kegg kegg:D07875 assertion.
- drugbank:DB01142 drugbank_vocabulary:x-kegg kegg:C06971 assertion.
- drugbank:DB01142 drugbank_vocabulary:x-dpd dpd:1913425 assertion.
- drugbank:DB01142 drugbank_vocabulary:x-chebi chebi:4710 assertion.
- drugbank:DB01142 drugbank_vocabulary:x-atc atc:N06AA12 assertion.
- drugbank:DB01142 drugbank_vocabulary:x-ahfs ahfs:84:08.00 assertion.
- drugbank:DB01142 drugbank_vocabulary:x-ndc ndc:0378-1049-01 assertion.
- drugbank:DB01142 drugbank_vocabulary:x-iuphar iuphar:1225 assertion.
- drugbank:DB01142 drugbank_vocabulary:x-gtp gtp:1225 assertion.